StockData
Pacira BioSciences, Inc. logo

Pacira BioSciences, Inc. (PCRX) stock

PCRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/3028% above fair value
$36.48+0.02 (+0.05%)

Close on Nov 16, 2026Market cap $1.45BP/E 104.2Yield –

Pacira BioSciences total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

Pacira BioSciences's total debt was $363.12M at Jun 30, 2026. For fiscal 2025 it was $372.19M, down 36.4% from the year before. The highest annual figure on record is $585.32M in fiscal 2024.

Annual total debt

PeriodPeriod endValueChange
FY2025Dec 31, 2025$372.19M-36.4%
FY2024Dec 31, 2024$585.32M+393.8%
FY2016Dec 31, 2016$118.53M-0.0%
FY2015Dec 31, 2015$118.53M-1.2%
FY2014Dec 31, 2014$120.00M0.0%
FY2013Dec 31, 2013$120.00M+376.4%
FY2012Dec 31, 2012$25.19M-1.5%
FY2011Dec 31, 2011$25.58M+2.1%
FY2010Dec 31, 2010$25.05M–

Quarterly total debt

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$363.12M-38.0%
Q1 FY2026Mar 31, 2026$367.66M+210.2%
Q4 FY2025Dec 31, 2025$372.19M–
Q3 FY2025Sep 30, 2025$376.72M–
Q4 FY2024Dec 31, 2024$585.32M–
Q4 FY2016Dec 31, 2016$118.53M–

More Pacira BioSciences figures

See a number that looks wrong?